# Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS

> **NCT03660228** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 62 (actual)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **OTHER:** Peri-Transfusion QOL Assessment

## Key facts

- **NCT ID:** NCT03660228
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-17
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660228, "Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03660228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*